Robert Glassman, a healthcare pro who advised Pfizer on its purchase of Wyeth last year, has returned to Bank of America Merrill Lynch as a managing director on its healthcare corporate and investment banking team.

Glassman was for the last year a private-equity partner at Orbimed Advisors, the world’s largest healthcare-dedicated investment firm. Bank of America Merrill Lynch announced his return in a press release on Wednesday.

Register or login for access to this item and much more

All Financial Planning content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access